Citation Impact
Citing Papers
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
2017
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
2017
Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents
2013
Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis
2017
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
2018
Pancreatic cancer
2020 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort
2014
Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage
2007
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive
2008
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
2013
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
2007
Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment
2008
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
The NAFLD fibrosis score
2007 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
Crohn's disease
2016 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Risk Assessment of Hepatocellular Carcinoma in Chronic Hepatitis C Patients by Transient Elastography
2008
Transient Elastography for the Noninvasive Assessment of Liver Fibrosis: A Multicentre Canadian Study
2010
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
2015
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis
2007
Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond
2020
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
2016
Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography
2008
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Non-invasive evaluation of liver fibrosis using transient elastography
2008
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Sofosbuvir: A Review of its Use in Patients with Chronic Hepatitis C
2014
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
2015
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
2016
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
2009
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C
2009
Hepatocellular carcinoma
2022 Standout
Noninvasive assessment of fibrosis and steatosis in NASH and ASH
2009
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Local and Regional Therapies for Hepatocellular Carcinoma
2020
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
A Comprehensive Computational Analysis for the Binding Modes of Hepatitis C Virus NS5A Inhibitors: The Question of Symmetry
2016 StandoutNobel
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
How I treat hemochromatosis
2010
Comprehensive Geriatric Assessment for Older Patients With Cancer
2007
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Noninvasive diagnosis of nonalcoholic fatty liver disease
2009
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
Works of Xavier Adhoute being referenced
Chronic hepatitis C: Treatments of the future
2011
Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?
2015
Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations
2006
Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: A prospective study
2008
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
2014
Diagnosis of liver fibrosis by transient elastography (FibroScan) and non‐invasive methods in Crohn's disease patients treated with methotrexate
2006
Surgical Resection after Radiochemotherapy in Patients with Unresectable Adenocarcinoma of the Pancreas
2005
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis
2015
Chronic hepatitis C: future treatment
2014
O14 Screening of elderly patient with cancer for early death risk. Results of a prospective multicentric study of 364 patients under chemotherapy
2006